Caregiver experiences with accessing sickle cell care and the use of telemedicine
BMC Health Services Research volume 22, Article number: 239 (2022)
Sickle cell disease (SCD) is associated with a wide range of complications. However, a multitude of barriers prevent SCD patients from receiving adequate healthcare, including difficulties with transportation and lack of provider knowledge about disease sequelae. Importantly, studies have demonstrated the benefits of telemedicine in addressing barriers to healthcare. While previous studies have identified barriers to care through quantitative methods, few studies have explored barriers which affect the pediatric SCD patient population in the Midwest, wherein the geographical landscape can prohibit healthcare access. Furthermore, few studies have established acceptability of telemedicine among caregivers and patients with SCD.
This study aims to increase understanding of barriers to care and perceptions of telemedicine by caregivers of pediatric SCD patients in a medically under-resourced area in the Midwest. Researchers conducted semi-structured interviews with caregivers of children with SCD. The interviews were audio-recorded and transcribed. Thematic analyses were performed.
Researchers interviewed 16 caregivers of 15 children with SCD. Thematic analyses of the interview transcripts revealed four broad themes regarding caregiver burden/stress, both facilitators and barriers to SCD healthcare, and general thoughts on the acceptability/usefulness of telemedicine.
This qualitative study describes common burdens faced by caregivers of SCD, barriers to and facilitators of SCD care in the Midwest, and caregiver perceptions of the usefulness and efficacy of telemedicine for SCD care.
Sickle cell disease (SCD) is the most common inherited hematologic disease in the world, disproportionately affecting African Americans in the United States . One out of every 365 African American newborns is diagnosed with SCD, many of whom are born into low-income families [1, 2]. The complications of SCD are numerous, and include severe pain, acute chest syndrome, and stroke . However, improvements in preventative therapies have increased the life span for patients with SCD, with more than 93% of children with SCD surviving to adulthood . Improved patient outcomes though, are contingent on SCD patients receiving timely evidence-based medical care, including regular patient evaluations with hematologists, disease-specific education, psychosocial care, and genetic counseling [5,6,7].
Despite the complexity of care required by SCD patients, many barriers prevent equitable access to healthcare [1, 8, 9]. Children with SCD experience longer than average emergency department (ED) wait times, difficulty with transportation, and insufficient availability of primary care providers . Additionally, primary care providers report having inadequate SCD expertise, feeling uncomfortable with pain management, and other SCD-related care for prevention and treatment [11, 12]. Comprehensive Sickle Cell Centers are more commonly located in major metropolitan areas, creating additional challenges for families living in rural or under-resourced areas .
While previous studies have identified barriers to accessing care for adults with SCD, less is understood about the barriers that affect the pediatric SCD patient population . Furthermore, there is limited data regarding barriers for those living in the Midwest, specifically in rural and medically under-resourced communities [1, 15, 16]. Telemedicine, the remote provision of medical care using real-time audio-visual consultation, is a valuable solution to addressing physician shortages and geographic barriers faced by patients and has proven successful for consultations in a variety of pediatric specialties . However, information on the value of telemedicine exclusively for SCD patients is minimal in the existing literature, particularly for children with SCD [18,19,20]. Additionally, attitudes of caregivers and patients with SCD regarding the use of technology, such as telemedicine, for addressing these barriers are not well established [21, 22].
Semi-structured interviews have proven to be a powerful tool for providers to gain a deeper understanding of patient experiences . This study aims to increase the understanding of both facilitators and barriers to care, as well as perceptions of telemedicine by caregivers of pediatric SCD patients in a medically under-resourced area in the Midwest.
Caregivers of pediatric patients with SCD seen at Riley Hospital for Children in Indianapolis, Indiana and live greater than 60 minutes from the hospital were contacted by the research team via phone or email. Those who did not meet these criteria were excluded. A total of 31 caregivers were asked to participate in a 30-min interview to understand facilitators and barriers to accessing sickle cell care, as well as acceptability of telemedicine for SCD care. Sixteen caregivers agreed to participate (response = 52%). The interviews were conducted by 2 members of the research team via Zoom or telephone, depending on the participant’s preference. At the beginning of the interview, the researcher and participant went over the study information sheet together, after which a standard consent procedure was conducted. Participants were compensated with a gift card for their time. This study was approved by the Indiana University Institutional Review Board.
The semi-structured interviews were conducted between March and October of 2021 and were audio-recorded. Interview questions were developed from literature review, including adaption of questions related to expectations and pragmatic barriers from the Barriers to Care Questionnaire (BCQ) by Seid et al. . The interviewer took notes and completed a field note following each interview.
Each interview was transcribed and subsequently coded by two authors. We used a thematic approach to analysis . A codebook was created based on findings from literature review and refined/expanded with re-occurring themes encountered during review of transcripts. Example codes included barriers to care, facilitators of care, and acceptability of telemedicine. Any discrepancies were reviewed by the remaining authors. The authors were all in agreement that the completed interviews reached theoretical saturation , providing adequate representation of attitudes given the emergence of common themes with little new variation.
A total of 16 caregivers of 15 children with SCD were interviewed (Table 1). Fourteen of the caregivers identified as female and as the primary caregiver. The majority of caregivers identified as Black (n = 11). On average, caregivers reported traveling 115 minutes one-way to receive SCD care. Fourteen of sixteen caregivers had participated in some model of telemedicine previously (e.g., hub-and-spoke or direct-to-consumer). Interviews lasted approximately 25 minutes (range 12–58 min).
Thematic analyses of the interview transcripts revealed 4 broad themes regarding caregiver burden/stress, barriers or facilitators to healthcare accessibility for children with SCD and their families, as well as usefulness of telemedicine (Table 2).
Caring for a child with a chronic medical condition can lead to significant caregiver stress . When discussing the experience of caregivers caring for their child with SCD, the majority (n = 12) reported feeling overwhelmed with the initial diagnosis and ongoing care. Caregivers reported the intermittent, unpredictable nature of the disease and its complications, as well as the feeling of helplessness during times of illness, can increase the stress they experience.
Caregivers also identified feelings of guilt and personal responsibility surrounding their child’s diagnosis of SCD. Five of the sixteen caregivers felt as though it was their fault that they were unaware they and their partner carried the sickle cell trait ultimately inherited by their child.
“I was really sad because I know that he’s going to have to deal with it for the rest of his life, and there’s nothing that I can really do, and then I felt kind of responsible for it because I didn’t know that I had the trait, and I didn’t know that his father had the trait, so I kind of felt responsible...like it was my fault that my son has this disease.”
The increased burden and stress caregivers experience as a result of caring for a child with a chronic disease has been shown to be associated with increased mental health concerns for the caregiver [28,29,30,31,32,33,34,35]. Six of the sixteen caregivers in our study expressed concern about how their personal mental health has suffered.
Barriers to care
Caregivers were asked about both perceived and experienced barriers to accessing the necessary healthcare for their child. Common themes included the distance to the subspecialty SCD center and associated transportation needs, as well as financial strain and missed days of work. Fourteen of sixteen caregivers cited at least one of these areas as a barrier. Eleven caregivers also reported missing school as a hardship for their child that is associated with accessing needed SCD care.
Lack of provider knowledge and comfort associated with sickle cell care has been discussed previously, both amongst primary care providers and ED providers . The majority (n = 9) of caregivers identified this as a concern within the general community, such as the school system, as well as within the medical system. Intertwined with this concern of provider knowledge and comfort regarding SCD, caregivers also reported the concern for provider bias .
Facilitators to care
Fourteen of the sixteen caregivers interviewed discussed how having subspecialists knowledgeable about SCD in the same space at the same time allowed for more convenient care, reducing the burden they experienced as a caregiver of a child with a chronic disease.
Dedicated sickle cell team/experts
Caregivers (n = 9) named access to hospital staff via phone/email and the ability to communicate with staff who are knowledgeable about SCD and familiar with their child as a facilitator of accessing SCD care. They appreciated being able to access a team directly that is dedicated to SCD, and felt this also led to prompt responses/solutions.
View of telemedicine
Telemedicine has been shown to improve access to care for children with complex medical needs who live in rural or medically under-resourced areas. Due to the ongoing COVID-19 pandemic, many patients and families, including our population, have participated in either hub-and-spoke or direct-to-consumer models of telemedicine. Hub-and-spoke telemedicine involves a specialist at a tertiary care center (hub) meeting virtually with the patient who is present at a local clinic site (spoke), whereas the direct-to-consumer model, which is the predominant form of telemedicine used during the current pandemic, connects the specialist virtually to the patient directly in their home. Most caregivers in our study stated telemedicine was beneficial, as it removes the barrier of distance/transportation to regular visits. Many also acknowledged the flexibility of telemedicine to allow for visits should there be difficulty for the family to be seen in person, or in the case of a pandemic, during spikes in cases.
Only 4 out of 16 caregivers who had participated in direct-to-consumer telemedicine mentioned difficulty with technology as a reason they would not want to regularly utilize this form of care delivery.
“A lot of times we do it on our phone and if you receive a call or something, you're kicked out. Then they have to get back on and redo everything…It's just that technical part of it is kind of frustrating sometimes.”
Lack of physical exam
Thirteen out of sixteen caregivers, all of whom had participated in direct-to-consumer telemedicine, cited the lack of a physical exam as a major reason why they did not prefer that model of telemedicine for visits. Caregivers reported they had a greater sense of reassurance that their child was well when an in-person exam was performed.
The lack of subspecialty centers for SCD compared to other genetic diseases has been well-documented [6, 38]. Fewer than 70% of children with SCD receive comprehensive subspecialty care, and only 20% experience effective care coordination between primary and subspecialty providers . Although Crosby et al., have reported barriers to care experienced by individuals living with SCD, the effect of living in a largely rural midwestern state with medically under-resourced urban areas has not been well-described . This qualitative study explored the experiences of caregivers in accessing healthcare for their child with SCD in rural and/or medically under-resourced areas of a midwestern state, as well as the use of telemedicine to overcome potential barriers.
The themes that emerged from the caregiver interviews in this study were consistent with barriers identified in previous research. However, these interviews revealed provider knowledge and bias as a novel, yet significant, barrier to receiving adequate SCD care. Caregivers often mentioned that they worry about how knowledgeable school personnel or a healthcare provider may be regarding SCD, and how this not only affects them personally, but also impacts their overall experience in the healthcare system. Caregivers expressed losing trust in their local community and hospitals because of this lack of knowledge, or worse, blatant bias (e.g., “…called drug seekers…”).
Trust of medical providers and the healthcare system is essential for ongoing care and shared decision-making in chronic diseases like SCD. It is especially important to build trust with patients with SCD and their caregivers, given that they generally comprise a particularly vulnerable population which has long been neglected and subject to racism in the healthcare system. Lack of provider knowledge or comfort with managing SCD not only increases this vulnerability and caregiver burden, but also furthers the development of medical mistrust. A focus on improving provider knowledge and addressing bias in the care of patients with SCD is essential to reducing barriers to accessing medical care . Standardization of care through sickle cell-specific protocols, personalized pain plans, and broad provider education can address some of these concerns.
Another specific theme that caregivers frequently mentioned was related to long-term stress and mental health burden. Caregiver stress and the development or worsening of mental health has been well-documented, including in other chronic disease populations such as cystic fibrosis . Additionally, caregiver perceptions of their child’s stress are associated with increased caregiver burden and worsening mental health . Caregivers in our study reported worsening of their own mental health due to their child having a chronic disease, as well as the challenges associated with accessing care for their child. Thus, not only are they enduring the stress and burden of caring for a child with a lifelong illness, but also the structural inequities that lead to poorer access to care or quality of care adds to their burden and overall mental well-being.
To improve the access patients with SCD and their caregivers have to subspecialists with expertise in SCD, telemedicine has been piloted in similar rural and medically under-resourced communities . The COVID-19 pandemic led to the mass adoption of the direct-to-consumer model of telemedicine, where the healthcare provider could deliver medical services directly to the patient in their home, often via a smartphone or tablet. This greatly increased the general population’s exposure to telemedicine, including individuals living with SCD. In our interviews, many of the caregivers had participated in some model of telemedicine. Interestingly, most who had experienced the direct-to-consumer model of telemedicine delivery thought a significant disadvantage was the lack of a hands-on physical exam. They viewed this disadvantage as significant enough that they would prefer to travel the distance to the subspecialty center to receive personalized care, despite the barriers that exist. The caregivers who had participated in the hub-and-spoke model of telemedicine for SCD care, did not report this as a disadvantage.
The barriers that caregivers of children with SCD experience in the Midwest have similarities to those previously reported in other parts of the U.S, and while telemedicine has been a useful adjunct to medical care during the COVID-19 pandemic, much still needs to be improved to provide adequate subspecialized care for the SCD population. Likely, there is value to leveraging multiple models of telemedicine (e.g., hub-and-spoke and direct-to-consumer) depending on the needs of the patient/caregiver, location, and disease severity. It may improve access to subspecialty care, but more importantly, similar to what has been done in pediatric diabetes care, these models need to be adapted to specifically serve the SCD population . Further work evaluating adapted models for SCD care is needed to improve access to healthcare for this patient population.
Like all studies, this one has limitations that should be considered. The small, focused sample size representing a population in the Midwest can limit generalizability outside of the region. However, the sample size was adequate to achieve thematic saturation, demonstrating consistency in reported themes . The study was also limited to caregivers of children and adolescents with SCD, and future studies evaluating perceptions and experiences of adolescent and young adult SCD patients living in rural or medically under-resourced areas would be of importance.
This qualitative study evaluates the experiences and perceptions of barriers to accessing SCD care for caregivers living in rural and medically under-resourced areas. While some reported themes overlapped with previous qualitative studies, those related to caregiver burden and provider knowledge or biases suggest barriers to care that may be unique to SCD patients, requiring interventions and models of care to be adapted for this specific population.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Sickle Cell Disease
Barriers to Care Questionnaire
Brennan-Cook J, Bonnabeau E, Aponte R, Augustin C, Tanabe P. Barriers to care for persons with sickle cell disease: the case manager’s opportunity to improve patient outcomes. Prof Case Manag. 2018;23(4):213–9.
CDC. Data & Statistics on Sickle Cell Disease [updated 12/16/2020]. Available from: https://www.cdc.gov/ncbddd/sicklecell/data.html. Accessed Oct 2021.
Dale JC, Cochran CJ, Roy L, Jernigan E, Buchanan GR. Health-related quality of life in children and adolescents with sickle cell disease. J Pediatr Health Care. 2011;25(4):208–15.
Wang CJ, Kavanagh PL, Little AA, Holliman JB, Sprinz PG. Quality-of-care indicators for children with sickle cell disease. Pediatrics. 2011;128(3):484–93.
Kanter J, Kruse-Jarres R. Management of sickle cell disease from childhood through adulthood. Blood Rev. 2013;27(6):279–87.
Grosse SD, Schechter MS, Kulkarni R, Lloyd-Puryear MA, Strickland B, Trevathan E. Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics. 2009;123(1):407–12.
Leschke J, Panepinto JA, Nimmer M, Hoffmann RG, Yan K, Brousseau DC. Outpatient follow-up and rehospitalizations for sickle cell disease patients. Pediatr Blood Cancer. 2012;58(3):406–9.
Raphael JL, Kamdar A, Wang T, Liu H, Mahoney DH, Mueller BU. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease. Pediatr Blood Cancer. 2008;51(3):398–401.
Liem RI, O'Suoji C, Kingsberry PS, Pelligra SA, Kwon S, Mason M, et al. Access to patient-centered medical homes in children with sickle cell disease. Matern Child Health J. 2014;18(8):1854–62.
Boulet SL, Yanni EA, Creary MS, Olney RS. Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med. 2010;38(4 Suppl):S528–35.
Haywood C Jr, Beach MC, Lanzkron S, Strouse JJ, Wilson R, Park H, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc. 2009;101(10):1022–33.
Mainous AG 3rd, Tanner RJ, Harle CA, Baker R, Shokar NK, Hulihan MM. Attitudes toward management of sickle cell disease and its complications: a national survey of academic family physicians. Anemia. 2015;2015:853835.
Shankar SM, Arbogast PG, Mitchel E, Ding H, Wang WC, Griffin MR. Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease. Pediatr Blood Cancer. 2008;50(1):66–71.
Bemrich-Stolz CJ, Halanych JH, Howard TH, Hilliard LM, Lebensburger JD. Exploring adult care experiences and barriers to transition in adult patients with sickle cell disease. Int J Hematol Ther. 2015;1(1):10.15436/2381–1404.15.003. https://doi.org/10.15436/2381-1404.15.003.
Crosby LE, Modi AC, Lemanek KL, Guilfoyle SM, Kalinyak KA, Mitchell MJ. Perceived barriers to clinic appointments for adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2009;31(8):571–6.
Hoegy D, Guilloux R, Bleyzac N, Gauthier-Vasserot A, Cannas G, Bertrand Y, et al. Sickle cell disease perceptions of caregivers, adolescent, and adult patients: barriers and facilitators to medical care adherence. J Adv Nurs. 2020;76(9):2391–400.
Marcin JP, Ellis J, Mawis R, Nagrampa E, Nesbitt TS, Dimand RJ. Using telemedicine to provide pediatric subspecialty care to children with special health care needs in an underserved rural community. Pediatrics. 2004;113(1):1–6.
Jacob SA, Carroll AE, Bennett WE Jr. A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved area. J Telemed Telecare. 2021;27(7):431–35. https://doi.org/10.1177/1357633X19883558.
Woods K, Kutlar A, Grigsby RK, Adams L, Stachura ME. Primary-care delivery for sickle cell patients in rural Georgia using telemedicine. Telemed J. 1998;4(4):353–61.
Woods KF, Johnson JA, Kutlar A, Daitch L, Stachura ME. Sickle cell disease telemedicine network for rural outreach. J Telemed Telecare. 2000;6(5):285–90.
Pletcher BA, Rimsza ME, Cull WL, Shipman SA, Shugerman RP, O'Connor KG. Primary care pediatricians’ satisfaction with subspecialty care, perceived supply, and barriers to care. J Pediatr. 2010;156(6):1011–5.e1.
Skinner AC, Slifkin RT. Rural/urban differences in barriers to and burden of care for children with special health care needs. J Rural Health. 2007;23(2):150–7.
DeJonckheere M, Vaughn LM. Semistructured interviewing in primary care research: a balance of relationship and rigour. Fam Med Community Health. 2019;7(2):e000057.
Seid M, Sobo EJ, Gelhard LR, Varni JW. Parents’ reports of barriers to care for children with special health care needs: development and validation of the barriers to care questionnaire. Ambul Pediatr. 2004;4(4):323–31.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
Grady MP. Qualitative and action research : a practitioner handbook. Bloomington: Phi Delta Kappa Educational Foundation; 1998. p. 55.
Toledano-Toledano F, Dominguez-Guedea MT. Psychosocial factors related with caregiver burden among families of children with chronic conditions. Biopsychosoc Med. 2019;13:6.
Kayaalp A, Page KJ, Rospenda KM. Caregiver burden, work-family conflict, family-work conflict, and mental health of caregivers: a mediational longitudinal study. Work Stress. 2021;35(3):217–40.
Penning MJ, Wu Z. Caregiver stress and mental health: impact of caregiving relationship and gender. Gerontologist. 2016;56(6):1102–13.
de Oliveira GR, Neto JF, de Camargo SM, Lucchetti ALG, Espinha DCM, Lucchetti G. Caregiving across the lifespan: comparing caregiver burden, mental health, and quality of life. Psychogeriatrics. 2015;15(2):123–32.
Pitchik HO, Tofail F, Akter F, Sultana J, Shoab A, Huda TMN, et al. Effects of the COVID-19 pandemic on caregiver mental health and the child caregiving environment in a low-resource, rural context. Child Dev. 2021;92(5):e764–e80.
Grosse J, Treml J, Kersting A. Impact of caregiver burden on mental health in bereaved caregivers of cancer patients: a systematic review. Psychooncology. 2018;27(3):757–67.
Chang HY, Chiou CJ, Chen NS. Impact of mental health and caregiver burden on family caregivers’ physical health. Arch Gerontol Geriatr. 2010;50(3):267–71.
Russell BS, Hutchison M, Tambling R, Tomkunas AJ, Horton AL. Initial challenges of caregiving during COVID-19: caregiver burden, mental health, and the parent-child relationship. Child Psychiatry Hum Dev. 2020;51(5):671–82.
Sheehan J, Hiscock H, Massie J, Jaffe A, Hay M. Caregiver coping, mental health and child problem behaviours in cystic fibrosis: a cross-sectional study. Int J Behav Med. 2014;21(2):211–20.
Martin OY, Thompson SM, Carroll AE, Jacob SA. Emergency department provider survey regarding acute sickle cell pain management. J Pediatr Hematol Oncol. 2020;42(6):375–80.
Haywood C Jr, Tanabe P, Naik R, Beach MC, Lanzkron S. The impact of race and disease on sickle cell patient wait times in the emergency department. Am J Emerg Med. 2013;31(4):651–6.
Farooq F, Mogayzel PJ, Lanzkron S, Haywood C, Strouse JJ. Comparison of US federal and foundation funding of research for sickle cell disease and cystic fibrosis and factors associated with research productivity. JAMA Netw Open. 2020;3(3):e201737.
Raphael JL, Rattler TL, Kowalkowski MA, Brousseau DC, Mueller BU, Giordano TP. Association of care in a medical home and health care utilization among children with sickle cell disease. J Natl Med Assoc. 2013;105(2):157–65.
Siminerio L, Ruppert K, Huber K, Toledo FG. Telemedicine for reach, education, access, and treatment (TREAT): linking telemedicine with diabetes self-management education to improve care in rural communities. Diabetes Educ. 2014;40(6):797–805.
Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523. https://doi.org/10.1016/j.socscimed.2021.114523.
We would like to thank all our patients with sickle cell disease and their families. Their courage and strength are an inspiration to us and the work we do.
Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K23HL143162. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Ethics approval and consent to participate
Ethical approval for this study was obtained from Indiana University Institutional Review Board (IRB). All methods were carried out in accordance with relevant guidelines and regulations of the Indiana University IRB. Informed consent was obtained from all participants included in the study.
Consent for publication
The authors have no conflicts of interest to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Jacob, S.A., Daas, R., Feliciano, A. et al. Caregiver experiences with accessing sickle cell care and the use of telemedicine. BMC Health Serv Res 22, 239 (2022). https://doi.org/10.1186/s12913-022-07627-w